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ABSTRACT 
A simple, precise and highly selective analytical method was developed for simultaneous estimation of Paracetamol and Etodolac in 
tablet formulation. Estimation was carried out by multicomponent mode of analysis at selected wavelength of 256 and 286 nm for 
Paracetamol (PCM) and Etodolac (ETD) respectively in methanol: water (60:40). The method was validated in terms of linearity, 
accuracy (% Recovery), Precision (Interday, intraday, and reproducibility) and robustness. Both methods were linear (R2 = 0.997- 
0.999 for UV method and 0.998 for RPLC method) and accurate (% recovery was 98.39-101.17%). The method was also obtained 
precise (% RSD <2 %) and robust. The linearity was obtained in the concentration ranges of 5.25 μg/ml for Paracetamol and 3-16 
μg/ml for Etodolac. The method was validated as per international conference of Harmonization (ICH) guidelines. 
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INTRODUCTION 
Paracetamol is one of the most popular over the counter 
drugs. It has analgesic and anti-pyretic properties with 
weak anti-inflammatory activity and it is used in the 
symptomatic management of moderate pain and fever. It 
is available in different dosage froms: tablet, capsules, 
drops, elixirs, suspensions and suppositories
1
. The drug 
is official in Indian, BP, European and US 
pharmacopoeias
2-5
.  
Paracetamol is chemically N-(N-hydroxyphenyl) 
acetamide 
6
 (fig: 1) is a member of Non-Steroidal Anti-
inflammatory Drugs (NSAIDs). Etodolac (ETD) is 
chemically 1,8- diethyl-1,3,4,9-tetrahydropyrano (3,4-b) 
indole-1- acetic acid (fig: 2)
 7
.  It is a member of Non-
Steroidal Anti-inflammatory Drugs (NSAIDs). Etodolac 
is official in indian, British, European and United State 
Pharmacopoeias. A combination of 500 mg of 
paracetamol and 400 mg etodolac is available 
commercially in tablet. This combination is used as 
analgesic and anti-pyretic in the treatment of 
osteoarthritis.  
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Figure 1: Structure of Paracetamol 
 
Figure 2: Structure of Etodolac 
A comprehensive literature research reveals the lack of a 
spectrophotometric analytical method for simultaneous 
estimation of paracetamol 
8-13
 and etodolac 
14-18 
in 
pharmaceutical formulations. A successful attempt was 
made to develop accurate, precise and sensitive multi-
component mode of analysis for estimation of both the 
drugs. The develop method is simple, rapid, selective, 
less expensive and less time consuming. The purpose of 
present study was to develop and validate 
spectrophotometric analytical methods for simultaneous 
estimation of paracetamol and etodolac in their 
combined tablet dosage from. 
MATERIALS AND METHODS 
Instrument: Instrument used was an UV-Visible double 
beam spectrophotometer Systronics-108 with a 
bandwidth of 1.5 nm and a pair of 1 cm matched quartz 
cells. The HPLC system consisted of a YL-9100 pump, 
a UV-visible detector, a Linhrocart C18 (250 x 4.60 
nm), 5µm column, a Lichrocart, HPLC guard Cartridge 
and YL-Clarity software. All weighing was done on 
analytical balance (Denver instrument, Germany). A 
sonicator (Electroquip ultra sonicator, Texas) was used 
in the study. Calibrated glass wares were used 
throughout the work. 
Chemicals: Chemicals used were methanol (Rankem 
Laboratories) and water (Merck Ltd., India). Marketed 
formulation containing Paracetamol 500 mg and 
Etodolac 400 mg (ETOGESIC-P) was procured from 
Burgeon Pharmaceuticals PVT LTD. Puducherry.  
METHOD 
Determination of λmax of Drugs:- 
Standard solution (10g/ml) of pure Paracetamol and 
Etodolac was prepared. The pure drug solutions were 
scanned on UV spectrophotometer, which showed 
maximum absorbance at 256.0 and 286.0 for 
Paracetamol and Etodolac respectively. 
Preparation of Standard Stock Solution: 
 10 mg of standard PCM and ETD were weighed 
separately and transferred to 100 ml separate volumetric 
flasks and dissolved in diluent (methanol: water in 
proportion of 60:40 (v/v)). The flasks were shaken and 
volumes were made up to mark with diluent to give a 
solution containing 100 μg/ml each of PCM and ETD.  
Methodology:  
The working standard solutions of PCM and ETD were 
prepared separately in diluent (methanol: water in 
proportion of 60:40 (v/v)) having concentration of 10 
μg/ml. They were scanned in the wavelength range of 
200- 400 nm against diluent methanol: water (60:40 v/v) 
as blank. λmax of both the drugs were 256 nm and 286 
nm for Paracetamol and Etodolac respectively. The 
absorption spectra thus obtained were derivatised from 
first to fourth order. First order derivative spectrum was 
selected for the analysis of both the drugs. From the 
overlain spectra of both the drugs wavelengths selected 
for quantitation were 224.28 nm (zero cross point for 
ETD) for PCM and 219.27 nm (zero cross point for 
PCM) for ETD.  
Validation of the Proposed Method:  
The proposed method was validated according to the 
International Conference on Harmonization (ICH) 
guidelines
19
.  
Linearity (Calibration Curve):  
Appropriate aliquots from the standard stock solutions 
of PCM and ETD were used to prepare two different 
sets of dilutions: Series A, and B as follows. Series A 
consisted of different concentration of PCM (5-25 
μg/ml). Appropriate aliquot from the stock solution of 
PCM (100 μg/ml) was pipette out in to a series of 10 ml 
volumetric flask and diluted with diluent to get final 
concentration in range of 5-25 μg/ml.  
Series B consisted of varying concentrations of ETD (3-
16 μg/ml). Appropriate aliquot of the stock solution of 
ETD (100 μg/ml) was transferred into a series of 10 ml 
volumetric flask and the volume was adjusted to the 
mark with diluent to get final concentration in range of 
3-16 μg/ml. The calibration curves were constructed by 
plotting drug concentration versus the absorbance values 
of first derivative spectrum at 224.28 nm for PCM and 
219.27 nm for ETD. The concentration of individual 
drugs present in the mixture was determined from the 
calibration curves in quantitation mode. 
Precision:  
The reproducibility of the proposed method was 
determined by performing the assay for the same day 
(intraday assay precision) and on three different days 
(inter day precision). Precision studies were performed 
by preparing nine determinations covering the specified 
range for the procedure (3 x 3 replicates for each 
concentration). Low % RSD shows that the method has 
good precision. The results of intraday and inter day 
precision were expressed in % RSD.  
Accuracy:  
The accuracy of the method was determined by 
calculating the recoveries of PCM and ETD by the 
standard addition method. Known amounts of standard 
solutions of PCM and ETD were added at 80 %, 100 % 
and 120 % level to prequantified sample solutions of 
PCM and ETD (10 μg/ml for PCM and 8 μg/ml for 
ETD). The amounts of PCM and ETD were estimated 
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by applying obtained observation values to the 
respective regression line. The results of accuracy were 
expressed in % Recovery.  
Limit of Detection and Limit of Quantification: 
 The LOD and LOQ were separately determined based 
on the standard calibration curve. The residual standard 
deviation of y-intercept of regression lines may be used 
to calculate LOD and LOQ using following equations.  
 LOD = 3.3 * D/S  
 LOQ = 10 * D/S  
Where, D = Standard deviation of the intercepts of 
regression line  
 S = Slope of the calibration curve
 
 
Figure 3: Overlain of derivative spectrum (1st order) of PCM and ETD 
 
Figure 4: Standard Calibration Curve of Pure Paracetamol 
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Table 1: Statistical parameter of the calibration curve 
Statistical Parameter  PCM ETD 
λmax 256nm  286nm 
Linearity range 5-25μg/ml  3-16μg/ml 
Linearity equation y = 0.0017X-0.0012  y = 0.0033X+0.0043 
Slope 0.0017 0.0032 
Intercept 0.0011 0.0044 
Standard deviation of slope 0.00004 0.000055 
Standard deviation of intercept 0.00017 0.00036 
Correlation co-efficient 0.9994  0.9983 
 
Table 2: Intraday precision data for PCM and ETD    
PCM     ETD    
Conc. Mean absorbance at % RSD Conc. Mean absorbance at % RSD 
(µg/ml) 227.28 nm ± SD   (µg/ml) 223.56 nm ± SD   
 (n=3)     (n=3)   
5 0.006   1.14 2 0.009 0.89  
15 0.023   1.49 10 0.035 1.24  
25 0.039   1.01 18 0.058 0.73  
Table 3: Inter day precision data for PCM and ETD    
PCM     ETD    
Conc. Mean absorbance at % RSD Conc. Mean absorbance at % RSD 
(µg/ml) 227.28 nm ± SD   (µg/ml) 223.56 nm ± SD   
 (n=3)     (n=3)   
5 0.007   1.23 2 0.010 0.65  
15 0.024   1.81 10 0.036 1.67  
25 0.042   1.58 18 0.056 1.67  
 
Table 4: Accuracy data for PCM and ETD    
Amt. of sample Amt.  of  std  drug Amt. recovered % Recovery ± SD 
( μg/ml)  added(μg/ml) (μg/ml)    
PCM ETD PCM ETD PCM ETD PCM ETD 
10 8 0 0 9.87 8.19 98.52±0.08 101.27±0.47 
10 8 8 6.5 16.96 13.45 98.39±0.12 98.76±0.45 
10 8 10 8 19.53 15.57 100.21±0.13 98.89±0.63 
10 8 12 9.7 21.47 16.17 101.14±0.13 97.72±0.57 
 
Table 5: Summary of validation parameters      
Parameter   PCM    ETD 
Linearity Range (µg/ml) 5-25    3-16  
Regression equation y = 0.0017X-0.0012  y = 0.0033X+0.0043 
correlation co-efficient 0.9994    0.9983 
Precision (% RSD)       
Intraday (n=3)   1.01-1.49    0.73-1.24 
Interday (n=3)   1.23-1.81    0.65-1.67 
Accuracy or Recovery (%) 98.39-101.14    97.72-101.27 
LOD (µg/ml)   0.33    0.36  
LOQ (µg/ml)   1.01    1.09  
         
Table 6: Assay result of marketed formulation   
Tablet Label claim (mg/tablet) Assay ± SD (% of label claim) 
 PCM  ETD PCM  ETD 
Etogesic-P 500  400 98.538 ± 0.2713  101.433 ± 0.2754 
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The calibration curves were constructed by plotting drug 
concentration versus the absorbance values of first 
derivative spectrum at 227.28 nm for PCM and 223.56 
nm for ETD. Standard calibration curves for PCM and 
ETD were linear with Correlation coefficients (r
2
) 
values in the range of 0.9994 and 0.9983 respectively at 
the selected wavelengths and the values were average of 
five readings. The Statistical parameter of the calibration 
curve was shown in table 1. 
LOD and LOQ were found to be 0.33 µg/ml and 1.01 
µg/ml for PCM and 0.36μg/ml and 1.09 μg/ml for ETD. 
Precision study showed co-efficient of variance (% CV) 
values less than 2 % for both PCM and ETD 
respectively. Result for the intra-day and inter-day 
precision was shown in table 2 and 3. 
RESULT AND DISCUSSION 
The accuracy of the method was confirmed by recovery 
studies from tablet at three different levels of 80 %, 100 
%, 120 % recovery in the range of 98.39 % – 101.27 % 
justifies the accuracy of method. The results obtained 
from the recoveries of both drugs shown in table 4. The 
overall summary of all validation parameter was shown 
in table 5 which was carried out as per ICH guidelines. 
The results of marketed pharmaceutical dosage forms 
analysis of the combinations are shown in table 6 which 
showed good agreement with the labeled claim. There 
was no interference was observed from the presence of 
excipients in the amounts, which are commonly present 
in tablet dosage forms. From all the present work we can 
conclude that the proposed UV spectrometric method 
for quantitative determination of PCM and ETD in 
combined dosage form was found to be simple, rapid, 
precise, accurate and sensitive. The excipients of the 
commercial sample analyzed did not interfere in the 
analysis, which proved the specificity of the method for 
these formulations. The developed method was found to 
be more reproducible and sensitive. 
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